Drug Shortage Report for RANITIDINE
Report ID | 93986 |
Drug Identification Number | 02353016 |
Brand name | RANITIDINE |
Common or Proper name | RANITIDINE |
Company Name | SANIS HEALTH INC |
Market Status | DORMANT |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2019-09-16 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2019-09-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-09-16 | English | Compare |
v2 | 2019-09-16 | French | Compare |
v3 | 2019-09-17 | English | Compare |
Showing 1 to 3 of 3